跳至主要内容
临床试验/NCT02679560
NCT02679560终止2 期

Effects of Liposomal Bupivacaine for Acute Pain in Hip and Femur Fractures: a Randomized, Active Comparator-controlled, Blinded Trial

Ian Elliott Brown1 个研究点 分布在 1 个国家目标入组 3 人开始时间: 2017年10月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
终止
发起方
入组人数
3
试验地点
1
主要终点
Opioid Requirements

研究概览

简要总结

This is an investigator-initiated, single-center, randomized, patient blinded, controlled trial. The purpose of this study is to compare the effect of a fascia iliaca compartment block (FICB) using 0.2% ropivacaine vs. liposomal bupivacaine in patients with femur and/or hip fractures admitted to the University of California Davis Medical Center (UCDMC). The primary endpoint will be the total opioid requirements during the 96 hour randomization period with secondary endpoints including total daily opioid requirements for days 1-4, duration of effect and objective pain scores using the numeric rating scale (NRS) during their hospital stay.

详细描述

In patients with femur or hip fractures, a fascia iliaca compartment block using liposomal bupivacaine will result in less total opioid administration during the randomization period compared to a fascia iliaca compartment block using 0.2% ropivacaine.

The long-term goal of this study is to provide pilot information to guide and design larger, multicenter trials which will evaluate the utility and cost-effectiveness of long acting liposomal bupivacaine as an opioid-sparring analgesic strategy in injured trauma patients. Ultimately, it is hoped that this information can improve safe and effective narcotic sparing analgesia in the awake, combat casualty, as well as serve as primary steps towards

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age ≥18 years ≤ 70 years
  • Patient's s/p trauma, with confirmed femur and/or hip fractures with a planned admission to the hospital
  • Patient is ambulatory without assistance (e.g. walker, cane, caretaker) prior to incident.

排除标准

  • >10 hours since presentation to the emergency department
  • History of seizure disorder, recent seizure or a document intra-cranial hemorrhage.
  • Central or peripheral neurologic deficit on presentation
  • Concern or compartment syndrome
  • Associated additional long bone fractures
  • End stage liver failure
  • Renal failure requiring dialysis
  • Pregnancy or breast feeding
  • Coagulopathy with INR >1.5
  • Use of direct thrombin inhibitors (bivalirudin, argatroban, desirudin, dabigatran etexilate), or direct factor Xa inhibitors (rivaroxaban, apixaban, edoxaban)
  • Suspected prolonged intubation within first 12 hours secondary to respiratory failure other than peri-procedurally
  • Adults unable to consent
  • Pediatric patients <18 years old
  • Patients exhibiting signs of shock upon admission, HR >120 or SBP <100 mmHg.
  • History of allergic reaction to local anesthetics
  • Administration of any other local anesthetic in the 2 hours prior to the study enrollment.
  • Distal femur fractures

研究组 & 干预措施

Liposomal Bupivacaine

Active Comparator

In patients with femur or hip fractures, a fascia iliaca compartment block using liposomal bupivacaine will be administered

干预措施: Liposomal Bupivacaine (Drug)

Ropivacaine HCL

Placebo Comparator

In patients with femur or hip fractures, a fascia iliaca block using using 0.2% ropivacaine will be administered

干预措施: Ropivacaine HCL (Drug)

结局指标

主要结局

Opioid Requirements

时间窗: Assessment time frame will be the initial 96 hours of inpatient status after study drug administration with a daily assessment of total daily opioid requirements and objective pain scores using the numeric rating scale.

Total opioid requirements during the 96 hour randomization period measured in milligram morphine equivalents

次要结局

  • Patient Outcomes(Assessment time frame will be the initial 96 hours of inpatient status after study drug administration with a daily assessment of total daily opioid requirements and objective pain scores using the numeric rating scale.)

研究者

发起方
Ian Elliott Brown
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Ian Elliott Brown

Assistant Professor of Surgery

University of California, Davis

研究点 (1)

Loading locations...

相似试验